NO20005795D0 - Antivirale forbindelser - Google Patents
Antivirale forbindelserInfo
- Publication number
- NO20005795D0 NO20005795D0 NO20005795A NO20005795A NO20005795D0 NO 20005795 D0 NO20005795 D0 NO 20005795D0 NO 20005795 A NO20005795 A NO 20005795A NO 20005795 A NO20005795 A NO 20005795A NO 20005795 D0 NO20005795 D0 NO 20005795D0
- Authority
- NO
- Norway
- Prior art keywords
- antiviral compounds
- antiviral
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1998/010299 WO1999059587A1 (en) | 1998-05-20 | 1998-05-20 | Anti-viral compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20005795D0 true NO20005795D0 (no) | 2000-11-16 |
NO20005795L NO20005795L (no) | 2001-01-18 |
Family
ID=22267098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20005795A NO20005795L (no) | 1998-05-20 | 2000-11-16 | Antivirale forbindelser |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1077701A4 (no) |
JP (1) | JP2002515433A (no) |
KR (1) | KR20010025055A (no) |
CN (1) | CN1292697A (no) |
AU (1) | AU7583098A (no) |
BR (1) | BR9815899A (no) |
CA (1) | CA2332403A1 (no) |
CZ (1) | CZ289425B6 (no) |
EA (1) | EA200001208A1 (no) |
HU (1) | HUP0102117A2 (no) |
IL (1) | IL139166A0 (no) |
NO (1) | NO20005795L (no) |
SK (1) | SK17482000A3 (no) |
TR (1) | TR200003414T2 (no) |
WO (1) | WO1999059587A1 (no) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPR213700A0 (en) | 2000-12-18 | 2001-01-25 | Biota Scientific Management Pty Ltd | Antiviral agents |
AR048650A1 (es) * | 2004-05-04 | 2006-05-10 | Tibotec Pharm Ltd | Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih |
ATE462697T1 (de) | 2004-08-12 | 2010-04-15 | Amgen Inc | Bisaryl-sulfonamide |
US7666880B2 (en) | 2005-03-21 | 2010-02-23 | S*Bio Pte Ltd. | Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications |
JP5206405B2 (ja) * | 2005-03-21 | 2013-06-12 | エムイーアイ・ファーマ・インコーポレイテッド | イミダゾ[1,2−a]ピリジン誘導体:製造および医薬用途 |
US7915411B2 (en) | 2005-12-21 | 2011-03-29 | Abbott Laboratories | Anti-viral compounds |
RU2467007C2 (ru) | 2005-12-21 | 2012-11-20 | Эбботт Лэборетриз | Производные [1,8]нафтиридина, полезные в качестве ингибиторов репликации вируса hcv |
WO2007076034A2 (en) | 2005-12-21 | 2007-07-05 | Abbott Laboratories | Anti-viral compounds |
CA2672737A1 (en) | 2006-12-20 | 2008-11-06 | Abbott Laboratories | Anti-viral compounds |
KR20110019759A (ko) * | 2008-05-27 | 2011-02-28 | 비오타 사이언티픽 매니지먼트 피티와이 엘티디 | 항바이러스 염 |
JP2012513409A (ja) | 2008-12-23 | 2012-06-14 | アボット・ラボラトリーズ | 抗ウイルス化合物 |
RU2505539C2 (ru) | 2008-12-23 | 2014-01-27 | Эбботт Лэборетриз | Антивирусные соединения |
WO2010120935A1 (en) * | 2009-04-15 | 2010-10-21 | Abbott Laboratories | Anti-viral compounds |
WO2014060381A1 (de) | 2012-10-18 | 2014-04-24 | Bayer Cropscience Ag | Heterocyclische verbindungen als schädlingsbekämpfungsmittel |
CN104884449A (zh) | 2012-10-31 | 2015-09-02 | 拜尔农作物科学股份公司 | 作为害虫防治剂的新的杂环化合物 |
CN104370732B (zh) * | 2014-01-26 | 2015-08-19 | 山东信立泰药业有限公司 | 一种氯吡格雷及其中间体的制备方法 |
CN109535405B (zh) * | 2017-09-21 | 2021-07-30 | 宁波聚嘉新材料科技有限公司 | 一种基于2-(4-羧基苯基)-5-羟基吡啶并咪唑的聚芳酯的制备方法 |
CN109810085B (zh) * | 2019-04-19 | 2019-07-19 | 上海皓元生物医药科技有限公司 | Acc抑制剂及其中间体的制备方法 |
CN110746450A (zh) * | 2019-09-17 | 2020-02-04 | 济南康和医药科技有限公司 | 一种贝前列素钠关键中间体的合成方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4096264A (en) * | 1975-12-09 | 1978-06-20 | Merck & Co., Inc. | Certain substituted imidazo [1,2-a] pyridines |
US4250174A (en) * | 1979-05-02 | 1981-02-10 | Merck & Co., Inc. | 3-Substituted imidazo [1,2-A] pyridines |
US5693661A (en) * | 1995-06-07 | 1997-12-02 | Eli Lilly And Company | Anti-viral compounds |
US5891874A (en) * | 1996-06-05 | 1999-04-06 | Eli Lilly And Company | Anti-viral compound |
CN1220601A (zh) * | 1996-06-05 | 1999-06-23 | 伊莱利利公司 | 抗病毒化合物 |
US5821242A (en) * | 1996-06-06 | 1998-10-13 | Eli Lilly And Company | Anti-viral compounds |
-
1998
- 1998-05-20 AU AU75830/98A patent/AU7583098A/en not_active Abandoned
- 1998-05-20 EP EP98923565A patent/EP1077701A4/en not_active Withdrawn
- 1998-05-20 WO PCT/US1998/010299 patent/WO1999059587A1/en not_active Application Discontinuation
- 1998-05-20 EA EA200001208A patent/EA200001208A1/ru unknown
- 1998-05-20 IL IL13916698A patent/IL139166A0/xx unknown
- 1998-05-20 SK SK1748-2000A patent/SK17482000A3/sk unknown
- 1998-05-20 CN CN988140519A patent/CN1292697A/zh active Pending
- 1998-05-20 KR KR1020007012999A patent/KR20010025055A/ko not_active Application Discontinuation
- 1998-05-20 CZ CZ20004278A patent/CZ289425B6/cs unknown
- 1998-05-20 BR BR9815899-6A patent/BR9815899A/pt not_active IP Right Cessation
- 1998-05-20 TR TR2000/03414T patent/TR200003414T2/xx unknown
- 1998-05-20 HU HU0102117A patent/HUP0102117A2/hu unknown
- 1998-05-20 CA CA002332403A patent/CA2332403A1/en not_active Abandoned
- 1998-05-20 JP JP2000549252A patent/JP2002515433A/ja not_active Withdrawn
-
2000
- 2000-11-16 NO NO20005795A patent/NO20005795L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
SK17482000A3 (sk) | 2005-03-04 |
NO20005795L (no) | 2001-01-18 |
IL139166A0 (en) | 2001-11-25 |
WO1999059587A1 (en) | 1999-11-25 |
HUP0102117A2 (hu) | 2001-12-28 |
CN1292697A (zh) | 2001-04-25 |
BR9815899A (pt) | 2001-02-20 |
EP1077701A1 (en) | 2001-02-28 |
CZ289425B6 (cs) | 2002-01-16 |
CA2332403A1 (en) | 1999-11-25 |
TR200003414T2 (tr) | 2001-03-21 |
KR20010025055A (ko) | 2001-03-26 |
EA200001208A1 (ru) | 2001-06-25 |
CZ20004278A3 (en) | 2001-05-16 |
AU7583098A (en) | 1999-12-06 |
JP2002515433A (ja) | 2002-05-28 |
EP1077701A4 (en) | 2002-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20010047D0 (no) | Antivirale makrocykliske forbindelser | |
BR9709643A (pt) | Compostos antivirais | |
LTPA2009006I1 (lt) | Trombopoetino junginiai | |
ATE229954T1 (de) | Betacarbolinverbindungen | |
ID28266A (id) | Senyawa-senyawa amidin | |
DK1070058T3 (da) | (4-Arylsulfonylamino)-tetrahydropyran-4-carboxylsyrehydroxamider | |
NO20011745L (no) | Forbindelser | |
NO20006520D0 (no) | Adenosinderivater | |
ID23287A (id) | Trisiklik tersubstitusi | |
DE69926033D1 (de) | Schlüsselkodekorrelationsanordnung | |
NO20005795D0 (no) | Antivirale forbindelser | |
ID27004A (id) | Senyawa-senyawa kalsilitik | |
ID23219A (id) | Trisiklik tersubstitusi | |
NO20006662D0 (no) | Fluorfenylresin-forbindelser | |
BR9709432A (pt) | Composto antivirais | |
NO20011358L (no) | Antivirale kombinasjoner | |
DK1054867T3 (da) | Antivirale midler | |
BR9709528A (pt) | Compostos antivirais | |
PT1076660E (pt) | (4-bromopirazol-3-il)-benzazolos substituidos | |
DE59912188D1 (de) | Substituierte phenyluracile | |
DE59911610D1 (de) | Substituierte benzoylcyclohexandione | |
ATE303996T1 (de) | Substituierte acylaminophenyl-uracile | |
SE9604179D0 (sv) | Antiviral compounds | |
SE9600614D0 (sv) | Antiviral compounds | |
SE9602566D0 (sv) | Antiviral compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |